At a glance
ClinicalIndex Comparison RecordN/ACompleted· 205 enrolled
Drug / intervention
Multidisciplinary team carebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicentre, Randomised Study to Examine the Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy
In Brief
A clinical study evaluating Multidisciplinary team care for Type 2 Diabetes Mellitus and DM Nephropathy. Completed, enrolled 205 participants across 1 site.
Detailed Summary
Disease management using a multidisciplinary team to achieve and maintain optimal metabolic and cardiovascular risk factors control in Type 2 diabetic patients with nephropathy reduces the incidence of end stage renal disease (ESRD) and improves clinical outcomes compared to usual clinic-based care
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus, DM Nephropathy
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2003
First PostedMar 2006
Primary CompletionDec 2007
TodayJul 2026
First PostedMar 31, 2006
Enrollment StartMay 1, 2003
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 20.3 years ago
Interventions
Multidisciplinary team carebehavioral